BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30835039)

  • 1. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer.
    Saleh AA; Soliman SE; Habib MSE; Gohar SF; Abo-Zeid GS
    Mol Biol Rep; 2019 Jun; 46(3):2809-2818. PubMed ID: 30835039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.
    Wang M; Zhang H; Yang F; Qiu R; Zhao X; Gong Z; Yu W; Zhou B; Shen B; Zhu W
    J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
    Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
    J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
    Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
    Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
    Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients.
    Ibrahim AM; Said MM; Hilal AM; Medhat AM; Abd Elsalam IM
    Tumour Biol; 2020 Oct; 42(10):1010428320963811. PubMed ID: 33028151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
    Papadaki C; Stratigos M; Markakis G; Spiliotaki M; Mastrostamatis G; Nikolaou C; Mavroudis D; Agelaki S
    Breast Cancer Res; 2018 Jul; 20(1):72. PubMed ID: 29996899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
    Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients.
    Said MN; Muawia S; Helal A; Fawzy A; Allam RM; Shafik NF
    Exp Mol Pathol; 2021 Dec; 123():104718. PubMed ID: 34752733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
    Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
    Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
    Liu W; Xu Y; Guan H; Meng H
    Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
    Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y
    PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
    Shaker O; Maher M; Nassar Y; Morcos G; Gad Z
    Gene; 2015 Apr; 560(1):77-82. PubMed ID: 25644077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
    Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
    Si H; Sun X; Chen Y; Cao Y; Chen S; Wang H; Hu C
    J Cancer Res Clin Oncol; 2013 Feb; 139(2):223-9. PubMed ID: 23052693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.